CD38 variation as a prognostic factor in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 55, Issue 1, 2014, Pages 191-194

  Nipp, Ryan D ^a   Volkheimer, Alicia D ^b   Davis, Evan D ^b   Chen, Youwei ^b   Weinberg, J Brice ^a,b   Friedman, Daphne R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN;

ANTIGEN EXPRESSION; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INTERPHASE; LETTER; LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891365248     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.786070     Document Type: Letter

References (7)

1. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
2. Deaglio S, Capobianco A, Bergui L, et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003; 102: 2146-2155.
3. Deaglio S, Vaisitti T, Aydin S, et al. C D38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood 2007; 110: 4012-4021.
4. Ghia P, Guida G, Stella S, et al. The pattern of CD38 expression defi nes a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 2003; 101: 1262-1269.
5. Hamblin TJ, Orchard JA, Ibbotson RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023-1029.
6. Ibrahim S, Keating M, Do KA, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181-186.
7. Weinberg JB, Volkheimer AD, Chen Y, et al. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia. Am J Hematol 2007; 82: 1063-1070.